These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16040085)

  • 21. Use of extended pattern technique for initial prostate biopsy.
    Siu W; Dunn RL; Shah RB; Wei JT
    J Urol; 2005 Aug; 174(2):505-9. PubMed ID: 16006881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative parameters to predict tumor volume in Japanese patients with nonpalpable prostate cancer.
    Furuya Y; Fuse H; Nagakawa O; Masai M
    Int J Clin Oncol; 2002 Apr; 7(2):109-13. PubMed ID: 12018107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A nomogram for predicting low-volume/low-grade prostate cancer: a tool in selecting patients for active surveillance.
    Nakanishi H; Wang X; Ochiai A; Trpkov K; Yilmaz A; Donnelly JB; Davis JW; Troncoso P; Babaian RJ
    Cancer; 2007 Dec; 110(11):2441-7. PubMed ID: 17932909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy.
    Chun FK; Suardi N; Capitanio U; Jeldres C; Ahyai S; Graefen M; Haese A; Steuber T; Erbersdobler A; Montorsi F; Huland H; Karakiewicz PI
    Eur Urol; 2009 Mar; 55(3):617-28-6. PubMed ID: 18499335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The independent impact of extended pattern biopsy on prostate cancer stage migration.
    Master VA; Chi T; Simko JP; Weinberg V; Carroll PR
    J Urol; 2005 Nov; 174(5):1789-93; discussion 1793. PubMed ID: 16217288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can contemporary transrectal prostate biopsy accurately select candidates for hemi-ablative focal therapy of prostate cancer?
    Tareen B; Godoy G; Sankin A; Temkin S; Lepor H; Taneja SS
    BJU Int; 2009 Jul; 104(2):195-9. PubMed ID: 19191784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate saturation biopsy in the reevaluation of microfocal prostate cancer.
    Boccon-Gibod LM; de Longchamps NB; Toublanc M; Boccon-Gibod LA; Ravery V
    J Urol; 2006 Sep; 176(3):961-3; discussion 963-4. PubMed ID: 16890668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increasing the number of biopsy cores improves the concordance of biopsy Gleason score to prostatectomy Gleason score.
    Coogan CL; Latchamsetty KC; Greenfield J; Corman JM; Lynch B; Porter CR
    BJU Int; 2005 Aug; 96(3):324-7. PubMed ID: 16042723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of pathological stages before prostatectomy in prostate cancer patients: analysis of 12 systematic prostate needle biopsy specimens.
    Park EA; Lee HJ; Kim KG; Kim SH; Lee SE; Choe GY
    Int J Urol; 2007 Aug; 14(8):704-8. PubMed ID: 17681059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of transrectal saturation biopsy in tumour localization: pathological correlation after retropubic radical prostatectomy and implication for focal ablative therapy.
    Abdollah F; Scattoni V; Raber M; Roscigno M; Briganti A; Suardi N; Gallina A; Capitanio U; Freschi M; Salonia A; Cestari A; Guazzoni G; Rigatti P; Montorsi F
    BJU Int; 2011 Aug; 108(3):366-71. PubMed ID: 21087451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study.
    Kvåle R; Møller B; Wahlqvist R; Fosså SD; Berner A; Busch C; Kyrdalen AE; Svindland A; Viset T; Halvorsen OJ
    BJU Int; 2009 Jun; 103(12):1647-54. PubMed ID: 19154461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The number of cores taken in patients diagnosed with a single microfocus at initial biopsy is a major predictor of insignificant prostate cancer.
    Villa L; Capitanio U; Briganti A; Abdollah F; Suardi N; Salonia A; Gallina A; Freschi M; Russo A; Castiglione F; Bianchi M; Rigatti P; Montorsi F; Scattoni V
    J Urol; 2013 Mar; 189(3):854-9. PubMed ID: 23022004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative prediction of unifocal, unilateral, margin-negative, and small volume prostate cancer.
    Iczkowski KA; Hossain D; Torkko KC; Qian J; Lucia MS; Wheeler TM; Rewcastle JC; Bostwick DG
    Urology; 2008 Jun; 71(6):1166-71. PubMed ID: 18279927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percentage of positive biopsy cores, preoperative prostate-specific antigen (PSA) level, pT and Gleason score as predictors of PSA recurrence after radical prostatectomy: a multi-institutional outcome study in Japan.
    Yokomizo A; Murai M; Baba S; Ogawa O; Tsukamoto T; Niwakawa M; Tobisu K; Kinukawa N; Naito S
    BJU Int; 2006 Sep; 98(3):549-53. PubMed ID: 16925752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Obtaining fresh prostate cancer tissue for research: a novel biopsy needle and sampling technique for radical prostatectomy specimens.
    Walton TJ; McCulloch TA; Rees RC; Bishop MC
    Prostate; 2005 Sep; 64(4):382-6. PubMed ID: 15754345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved accuracy in predicting the presence of Gleason pattern 4/5 prostate cancer by three-dimensional 26-core systematic biopsy.
    Numao N; Kawakami S; Yokoyama M; Yonese J; Arisawa C; Ishikawa Y; Ando M; Fukui I; Kihara K
    Eur Urol; 2007 Dec; 52(6):1663-8. PubMed ID: 17240041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate cancers scored as Gleason 6 on prostate biopsy are frequently Gleason 7 tumors at radical prostatectomy: implication on outcome.
    Pinthus JH; Witkos M; Fleshner NE; Sweet J; Evans A; Jewett MA; Krahn M; Alibhai S; Trachtenberg J
    J Urol; 2006 Sep; 176(3):979-84; discussion 984. PubMed ID: 16890675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Percentage of cancer in prostate biopsies as prognostic factor for staging and postoperative biochemical failure after radical prostatectomy.
    Villamón-Fort R; Martínez-Jabaloyas JM; Soriano-Sarriá P; Ramos-Soler D; Pastor-Hernández F; Gil-Salom M
    Urol Int; 2007; 78(4):328-33. PubMed ID: 17495491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates for active surveillance.
    Nakanishi H; Groskopf J; Fritsche HA; Bhadkamkar V; Blase A; Kumar SV; Davis JW; Troncoso P; Rittenhouse H; Babaian RJ
    J Urol; 2008 May; 179(5):1804-9; discussion 1809-10. PubMed ID: 18353398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extended 12-core prostate biopsy increases both the detection of prostate cancer and the accuracy of Gleason score.
    Elabbady AA; Khedr MM
    Eur Urol; 2006 Jan; 49(1):49-53; discussion 53. PubMed ID: 16314035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.